Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ANGO

Price
11.26
Stock movement up
+0.02 (0.18%)
Company name
AngioDynamics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
462.46M
Ent value
514.17M
Price/Sales
1.50
Price/Book
2.62
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-28.35%
1 year return (CAGR)
3.13%
3 year return (CAGR)
-4.94%
5 year return (CAGR)
-11.94%
10 year return (CAGR)
1.07%
Last updated: 2026-02-20

DIVIDENDS

ANGO does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.50
Price to Book2.62
EV to Sales1.67

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count41.22M
EPS (TTM)-0.67
FCF per share (TTM)-0.23

Income statement

Loading...
Income statement data
Revenue (TTM)307.31M
Gross profit (TTM)165.07M
Operating income (TTM)-28.91M
Net income (TTM)-27.71M
EPS (TTM)-0.67
EPS (1y forward)-0.11

Margins

Loading...
Margins data
Gross margin (TTM)53.72%
Operating margin (TTM)-9.41%
Profit margin (TTM)-9.02%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash41.64M
Net receivables44.43M
Total current assets161.35M
Goodwill0.00
Intangible assets66.73M
Property, plant and equipment0.00
Total assets269.68M
Accounts payable35.39M
Short/Current long term debt11.79M
Total current liabilities71.96M
Total liabilities93.35M
Shareholder's equity176.33M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-5.60M
Capital expenditures (TTM)3.73M
Free cash flow (TTM)-9.33M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-15.71%
Return on Assets-10.28%
Return on Invested Capital-15.56%
Cash Return on Invested Capital-5.24%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open11.34
Daily high11.36
Daily low11.07
Daily Volume227K
All-time high31.07
1y analyst estimate19.33
Beta0.50
EPS (TTM)-0.67
Dividend per share0.00
Ex-div date-
Next earnings date2 Apr 2026

Downside potential

Loading...
Downside potential data
ANGOS&P500
Current price drop from All-time high-63.76%-1.82%
Highest price drop-83.04%-56.47%
Date of highest drop25 Mar 20249 Mar 2009
Avg drop from high-47.56%-10.84%
Avg time to new high248 days12 days
Max time to new high4985 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ANGO (AngioDynamics Inc) company logo
Marketcap
462.46M
Marketcap category
Small-cap
Description
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Employees
675
Investor relations
-
SEC filings
CEO
James Christopher Clemmer
Country
USA
City
Latham
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...